-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

SAVIENT PHARMA Add to My Watchlist

(NSDQ: SVNT)

Detailed Quote

Last Price	13.81 (11.20.09 5:20 PM EST)
Change (%)	-0.19 (-1.36%)
Volume	1,304,809
Open	13.92
Previous Close	14.00
Day's Range	14.10 - 13.40
Bid / Ask	13.79 / 13.80

Intraday

3 Month

6 Month

1 Year

Average Volume	1,928,570	Shares Outstanding	66.63M
52-Week Range	2.98 - 16.62	Market Cap	920.1M
P/E Ratio	-6.9	Earnings Per Share	-2.01
Dividend	N/A	Yield	N/A

Symbol	Last	Change (%)
ONXX	27.99	+0.10 (+0.36%)
CRXLF	21.10	+0.00 (+0.00)
REGN	18.46	-0.21 (-1.12%)
ZLIXF	6.65	+0.00 (+0.00)
CRXL	21.62	+0.17 (+0.79%)

Wed, Sep 16, 2009
	Wednesday's biggest gaining and declining stocks Stocks expected to move significantly in trading on Wednesday include the European tech stocks as well as Adobe, Anadarko, ArcelorMittal, Martha Stewart Omnimedia, Omniture, Premiere Global, Rambus, Rockwell Automation, and Smithfield Foods. - MarketWatch
Thu, Jun 18, 2009
	Drug stocks mixed; Aastrom rallies on FDA nod Drug stocks are mixed in early action as shares of Aastrom Biosciences rally on news that U.S. regulators are allowing a key stem-cell therapy clinical trial to resume. - MarketWatch
Wed, Jun 17, 2009
	Savient rallies in broadly higher drug sector As drug and biotech stocks make broad early gains, shares of Savient Pharmaceuticals stand out, rallying nearly 30% as a Food and Drug Administration advisory panel recommends approval for its drug Krystexxa. - MarketWatch
Fri, Jun 12, 2009
	Biotech stocks slide as Euro vaccine makers gain Biotech stocks slide in early action while shares of European vaccine makers gain in the wake of Thursday's declaration of a formal flu pandemic by the World Health Organization. - MarketWatch
Tue, Apr 07, 2009
	Biotech Poised to Disappoint (MRK, GILD, CELG) The recent wave of big pharma acquisitions does not live up to hype. - Investopedia
More Featured Content

Fri, Nov 13, 2009
	AnalystChoice.com Initiates Research on SSRI, PLCE, SVNT, ARUN, STSI and TQNT NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). - Marketwire
Wed, Nov 04, 2009
	Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results - PR Newswire
	RothmanResearch.com Market Review and Company Analysis on SYNA, ARUN, CELG, SVNT, PRGN and SWHC NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by RothmanResearch.com. - Marketwire
Wed, Oct 28, 2009
	Savient Pharmaceuticals to Hold Third Quarter 2009 Financial Results Conference Call on Thursday, November 5, 2009 - PR Newswire
Tue, Oct 27, 2009
	Savient Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference - GlobeNewswire
More Press Releases

11/05/09		Q3 2009 Earnings Archive for SVNT
05/14/09		Special Conference Savient Pharmaceuticals Presents at the Bank of America and Merrill Lynch 2009 Health Care Conference Archive for SVNT
05/07/09		Q1 2009 Earnings Archive for SVNT
02/26/09		Q4 2008 Earnings Archive for SVNT
11/06/08		Q3 2008 Earnings Archive for SVNT

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Todd Harrison

Terry Woo

Kevin Depew

Jeff Macke

Andrew Jeffery

Jeffrey Cooper

Dr Janice Dorn

Allan Dodds Frank

John Mauldin

Smita Sadana